We tested here, using a replicating oncolytic virus (OV) that expresses IL-15/IL-15Rα (vvDD-IL15/Rα) in vivo, a strategy to enhance recovery of autologous tumor-specific memory CD8+ T cells which could be utilized for ACT. The gene discussed is CD8A; the disease is neoplasm.